← Back to Search

Behavioral Intervention

Cognitive Behavioral Therapy for Pancreatic Cancer Stress Management

N/A
Waitlist Available
Led By Frank Penedo, PhD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Greater than 18 years of age
Diagnosis of pancreatic cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 10 weeks.
Awards & highlights

Study Summary

This trial will test a new program to help reduce stress in pancreatic cancer patients.

Who is the study for?
This trial is for adults over 18 with pancreatic cancer who can read Spanish or English. They must be willing to participate in assessments from diagnosis through up to two years after surgery, if applicable. Those with severe mental illness history, other invasive cancers, or prior chemotherapy are excluded.Check my eligibility
What is being tested?
The study tests a web-based program designed to reduce stress in pancreatic cancer patients using Cognitive Behavioral Therapy (CBT)-based skills versus standard education about the disease and treatment.See study design
What are the potential side effects?
Since this trial involves psychological interventions rather than medications, traditional side effects are not expected. However, participants may experience emotional discomfort when discussing personal issues during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
I have been diagnosed with pancreatic cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 10 weeks.
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 10 weeks. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Health Related Quality of Life as Measured by Functional Assessment of Cancer Therapy (FACT) Hepatobiliary-Pancreatic Symptom Index (FHSI)-18
Health Related Quality of Life as Measured by Functional Assessment of Cancer Therapy General - 7 Item Version (FACT-G7)
Health Related Quality of Life as Measured by Interpersonal Support Evaluation List
+3 more
Secondary outcome measures
Biochemical Stress Response as measured by circulating peripheral blood mononuclear cells (PBMCs)
Biochemical Stress Response as measured by pro-inflammatory chemokine genes/receptors
Biochemical Stress Response as measured by pro-inflammatory cytokine genes
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Psychosocial Symptom Management Intervention (PSMI) Experimental Condition ArmExperimental Treatment1 Intervention
Participants in this group will receive the Cognitive Behavioral Therapy (CBT)-based skills over a 10-week period.
Group II: Usual Clinical Care Control ArmActive Control1 Intervention
Participants in this group will receive standard education.

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
911 Previous Clinical Trials
411,133 Total Patients Enrolled
1 Trials studying Psychological Adaptation
64 Patients Enrolled for Psychological Adaptation
Frank Penedo, PhDPrincipal InvestigatorUniversity of Miami
2 Previous Clinical Trials
700 Total Patients Enrolled
Frank PenedoPrincipal InvestigatorUniversity of Miami

Media Library

Cognitive Behavioral Therapy (CBT)-based skills (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04815746 — N/A
Psychological Adaptation Research Study Groups: Psychosocial Symptom Management Intervention (PSMI) Experimental Condition Arm, Usual Clinical Care Control Arm
Psychological Adaptation Clinical Trial 2023: Cognitive Behavioral Therapy (CBT)-based skills Highlights & Side Effects. Trial Name: NCT04815746 — N/A
Cognitive Behavioral Therapy (CBT)-based skills (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04815746 — N/A
~40 spots leftby Jun 2025